Related Experiment Video
Updated: Sep 18, 2025

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
Update on HDM Allergy: Principal Changes over the Years.
Krzysztof Jurkiewicz1, Marek Jutel1, Sylwia Smolinska1
1Department of Clinical Immunology, Faculty of Medicine, Wroclaw Medical University, Parkowa 34, 51-616 Wroclaw, Poland.
House dust mite (HDM) allergy affects millions globally, causing respiratory and skin conditions. New biomarkers and immunotherapy strategies offer personalized treatment options for this growing health concern.
Area of Science:
- Immunology
- Allergology
- Epidemiology
Background:
- House dust mites (HDMs) are significant indoor allergens triggering allergic rhinitis, asthma, and atopic dermatitis.
- Key HDM allergens include Der p 1, Der p 2, and Der p 23, implicated in allergic disease pathogenesis.
Purpose of the Study:
- To review the epidemiology, classification, and pathophysiology of HDM allergy.
- To discuss current and emerging allergen-specific immunotherapy (AIT) strategies.
- To highlight advancements in personalized AIT approaches.
Main Methods:
- Literature review of epidemiological data, microbiological classifications, and pathophysiological mechanisms.
- Analysis of current research on allergen-specific immunotherapy (AIT) and its efficacy.
- Examination of novel diagnostic biomarkers and therapeutic strategies.
Main Results:
- HDM allergy prevalence is increasing worldwide.
- Specific IgE to total IgE (sIgE/tIgE) ratio and regulatory follicular T cell profiles are emerging biomarkers for AIT efficacy.
- Recombinant allergens and peptide-based formulations represent promising new AIT approaches.
Conclusions:
- Optimizing diagnostics and treatment strategies for HDM allergy is essential.
- Personalized medicine, guided by predictive biomarkers, is advancing AIT.
- Continued research is vital to improve patient care and outcomes for HDM allergy.
Related Concept Videos
Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Cross-reactivity

